Navigation Links
New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics
Date:1/4/2009

de association study of hundreds of thousands of genetic markers using DNA samples from 1,052 individuals with ulcerative colitis and pre-exisiting data from 2,571 controls, all of European ancestry and residing in North America. Several genetic markers on chromosomes 1p36 and 12q15 showed highly significant associations with ulcerative colitis, and the association evidence was replicated in independent European ancestry samples from North America and southern Italy. Nearby genes implicated as possibly playing a role in ulcerative colitis include the ring finger protein 186 (RNF186), OTU domain containing 3 (OTUD3), and phospholipase A2, group IIE (PLA2G2E) genes on chromosome 1p36, and the interferon, gamma (IFNG), interleukin 26 (IL26), and interleukin 22 (IL22) genes on chromosome 12q15. RNF186 and OTUD3 are members of gene families involved in protein turnover and diverse cellular processes. PLA2G2E, IFNG, IL26 and IL22 are known to play a role in inflammation and the immune response. The study also found highly suggestive associations between ulcerative colitis and genetic markers on chromosome 7q31 within or near the laminin, beta 1 (LAMB1) gene, which is a member of a gene family known to play a role in intestinal health and disease, and confirmed previously identified associations between ulcerative colitis and genetic variants in the interleukin 23 receptor (IL23R) gene on chromosome 1p31 and the major histocompatibility complex on chromosome 6p21.

"My laboratory is focused on studying the genetic basis for IBD," said Dr. Duerr. "Through genetic mapping, we and our collaborators are successfully identifying regions of the genome that contain IBD genes. The next steps are to understand the functional significance of IBD-associated genetic variants, and then to develop new treatments that specifically target biological pathways implicated by the genetic discoveries. The overall goal of this work is to improve the lives of the millions of patients wo
'/>"/>

Contact: Courtney McCrimmon
McCrimmonCP@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Genetic variation may lead to early cardiovascular disease
2. Scientists make strides toward defining genetic signature of Alzheimers disease
3. Safe new therapy for genetic heart disease
4. NIST guides genetic genealogy labs toward improved accuracy
5. Ancient African exodus mostly involved men, geneticists find
6. VCU survey: US public supports genetic research, testing and government spending on research
7. Attitudes towards assisted reproduction and preimplantation genetic diagnosis
8. MU researcher identifies possible genetic causes of borderline personality disorder
9. CSHL researchers map changing epigenetic modifications that enable transposons to run amok
10. Irritable bowel syndrome can have genetic causes
11. New research shows how gene function drives natural selection in important class of genetic elements

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ing Harbor, N.Y. Oncologists have had their hands...have mutations that disable a protein called p53. ...s several cancer-fighting operations within cells.... often cannot be treated. , These tumors might ...ew study from Cold Spring Harbor Laboratory (CSHL)...
(Date:11/9/2009)...versity evolutionary biologists David Queller and ...peration and low conflict between components, from..."organismality," whether that thing is an animal, ...traits scientists use to describe an organism, suc...species, may not be necessary to achieve organisma...
(Date:11/9/2009)...f academic, government and industry researchers ha...esculenta) genome. The project is an important fir...is subsistence crop and addressing some of the man... world. , Cassava is a root crop that serves as ...people each day. Although it has many properties t...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3What is the meaning of 'one'? 2What is the meaning of 'one'? 3Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Injection May Heal Damaged Heart 52560 1Injection May Heal Damaged Heart 52560 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 1National Science Foundation Announces 2420M Research Award to South Carolina 52556 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 3More than 1 000 Underinsured and Uninsured Individuals Receive Free Dental Care 52553 1More than 1 000 Underinsured and Uninsured Individuals Receive Free Dental Care 52553 2
...) In an epidemiological study, Tufts University re...in a sample of the United States population based...LP) levels in the bloodstream. Plasma PLP is the i... current Recommended Dietary Allowance (RDA) of vi...function and important for maintaining a healthy i...
...reproduce, like all vertebrates, they either lay t... according to new research by a team of Boston Uni...ropsophus ebraccatus) in Panama that reproduces bo...ecision to lay egg masses aquatically in a pond or...ond, where the newly-hatched tadpoles simply fall ...
...quality at beaches along the Great Lakes have prom... safe for recreation. A new collaborative project ...rs when they are faced with deciding whether to cl...rative effort will draw on the expertise of U.S. G...l agencies. , The project has been funded throug...
Other Biology News:Study identifies trends of vitamin B6 status in US population sample 2Study identifies trends of vitamin B6 status in US population sample 3Reproductive plasticity revealed: Neotropical treefrog can choose to lay eggs in water or on land 2To swim or not to swim? 2
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TS...d that John Docherty, president and chief operatin...6th annual Investor Summit on November 10, 2009 at...r. Docherty will provide an overview of the Compan...nd Topical Interferon Alpha-2b. The slide show po...
(Date:11/6/2009)... ,, 3Q09 Corporate...a(TM) E.U. Marketing Authorization to Astellas Pha...mercial readiness activities Expanded management ...ng; and Director, Commercial Operations Appointed...t Committee chairman , Upcoming 2009 Milest...
(Date:11/6/2009)...PRNewswire/ -- Intarcia Therapeutics, Inc. deliver...#174; continuous delivery of exenatide) program fo...nual Diabetes Technology Meeting in San Francisco,...prnh/20050301/SFTU126LOGO ) ,, Continuous Sub...s Plasma Glucose, HbA1c and Reduces Weight in a 28...
(Date:11/5/2009)... GenVec, Inc. (Nasdaq: ...he third quarter ended September 30, 2009. GenVec ...re) for the three months ended September 30, 2009 ...share) in the comparable quarter of 2008. For the ... loss was $14.1 million ($0.15 per share), compare...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...ns, and great differences among countries. This i...to use previously collected samples from biobanks ...xtremely complicated to carry out major internatio...hnology, Swedish ethics researchers at the Center ... researchers, put forward a pioneering solution: a...
...w kind of biosensor can tell., A new and deceptiv...s at Vanderbilt University that can measure the in...ical molecules including proteins, sugars, antibod...capability needed to capitalize on the new avenues...ar-plus effort to sequence the human genome. DNA i...
...ound that the body,s innate ability to adapt to re...effective and less costly artificial respirators. ...nduced sedation or paralysis currently necessary f...associative learning, or our innate ability to ada...e described in the September 12 issue of PLoS ONE,...
Other Biology Technology:Long-awaited international ethical guidelines for biobank researchers 2When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell 2When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell 3MIT: Leveraging learning for artificial respiration 2
Anti-Human sRANKL Polyclonal Antibody, Biotin Conjugated from Cell Sciences
Mouse Anti-Human Procollagen Type I C-Peptide (PIP) Monoclonal Antibody, Unconjugated, Clone PC5-5 from QED Bioscience Inc.
Goat Anti-Human Factor VIII Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Mouse sRANKL Antibody, Biotin Conjugated from Cell Sciences
Biology Products: